海湾与中东 · 综合新闻 · Gulf Daily News
Johnson & Johnson's prostate cancer drug shrinks tumours in early-stage trial
Johnson & Johnson on Saturday said its experimental once-daily oral prostate cancer drug caused tumours to disappear or shrink in an early-stage trial. J&J had gained access to…
在 Gulf Daily News 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.gdnonline.com)


